January 15, 2026: Strive Specialties Accuses Trulicitys Maker of Blocking Patients from Low-Cost, Customized GLP-1s Strive Specialties is a compounding drug company that makes low-cost, customized versions of medications, and it helped formulate some GLP-1s during past shortages
Importantly, your dose may need to increase as your body adjusts and your weight loss progresses
Insurers, including Ambetter, almost universally classify this as a cosmetic procedure, leaving you to foot the entire bill, which can be just as expensive as the initial bariatric surgery
The 0.25mg starting dose becomes 10 units instead of 5
MeAgain is especially useful if your real question is: "How do I know what happened this week?" not just "Did I feel a symptom?" Bottom line: MeAgain is built for people who want to know what actually happened this week, not just whether a symptom occurred
A 2025 pilot IV study (1020mg, n=2) showed no adverse effects on biomarkers